iBio Inc (NASDAQ:IBIO) price on current trading day, rose 6.67% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.28.
A look at the stock’s price movement, the close in the last trading session was $1.20, moving within a range at $1.035 and $1.28. The beta value (5-Year monthly) was 1.022. Turning to its 52-week performance, $6.89 and $1.19 were the 52-week high and 52-week low respectively. Overall, IBIO moved -77.62% over the past month.
iBio Inc’s market cap currently stands at around $12.64 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-09.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 400k, representing a 77.78% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that IBIO is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 2 recommend IBIO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
IBIO’s current price about -67.23% and -68.82% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 20.78, while 7-day volatility ratio is 40.37% and 17.80% in the 30-day chart. Further, iBio Inc (IBIO) has a beta value of 1.57, and an average true range (ATR) of 0.57. Analysts have given the company’s stock an average 52-week price target of $3.6, forecast between a low of $3.6 and high of $3.6. Looking at the price targets, the low is -181.25% off current price level while to achieve the yearly target high, price needs to move -181.25%. Nonetheless, investors will most likely welcome a -181.25% jump to $3.6 which is the analysts’ median price.
If we refocus on iBio Inc (NASDAQ:IBIO), historical trading data shows that trading volumes averaged 0.99 over the past 10 days and 597.46K over the past 3 months. The company’s latest data on shares outstanding shows there are 9.87 million shares.
The 5.67% of iBio Inc’s shares are in the hands of company insiders while institutional holders own 26.65% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.85 million on 2025-03-14, giving us a short ratio of 0.9. The data shows that as of 2025-03-14 short interest in iBio Inc (IBIO) stood at 863.0000000000001 of shares outstanding, with shares short rising to 0.21 million registered in 2025-01-31. Current price change has pushed the stock -47.76% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IBIO stock continues to rise going into the next quarter.
